价格

CAR-GPRC5D

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

RECOMBINANT HUMANIZED MONOCLONAL ANTIBODY TARGETING HUMAN GPRC5D AND APPLICATION THEREOF
US 20260028398 A1申请人: SUZHOU DIMA BIOTECHNOLOGY CO LTD优先权: 2022
CN
EP
US
WO
4 件公开
ANTI-IDIOTYPIC ANTIBODIES TO GPRC5D-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS
US 2023192869 A1申请人: JUNO THERAPEUTICS INC优先权: 2019
CN
US
WO
4 件公开
COMBINATION THERAPIES WITH A CELL THERAPY EXPRESSING A GPRC5D-TARGETING CAR AND RELATED METHODS AND USES
- EP 4777540 A1
  申请人: JUNO THERAPEUTICS INC优先权: 2023
  CN
  EP
  WO
  3 件公开
- EP 4788373 A1
  申请人: JUNO THERAPEUTICS INC优先权: 2023
  CN
  EP
  WO
  3 件公开
POLYNUCLEOTIDE ENCODING NK CELL ENGAGER AND CAR, AND MODIFIED CELL COMPRISING POLYNUCLEOTIDE
WO 2025256558 A1申请人: GUANGZHOU ANJIE BIOMEDICAL TECH CO LTD优先权: 2024
CN
WO
3 件公开
靶向G-蛋白偶联受体的嵌合抗原受体及其用途
CN 113968912 B申请人: 纪念斯隆-凯特琳癌症中心优先权: 2014
CN
3 件公开
FULLY HUMAN ANTIBODY TARGETING GPRC5D AND CHIMERIC ANTIGEN RECEPTOR (CAR) AND USE THEREOF
US 20250049852 A1申请人: SHANGHAI IASO BIOTECHNOLOGY CO LTD优先权: 2021
CN
US
2 件公开
CARS AND CAR-NK CELLS TARGETING BOTH BCMA AND GPRC5D AND USE THEREOF IN TREATING MULTIPLE MYELOMA
WO 2025108429 A1申请人: WUXI BIOLOGICS SHANGHAI CO LTD优先权: 2023
CN
WO
2 件公开
BISPECIFIC CAR-T CELL TARGETING BCMA AND GPRC5D
WO 2026012487 A1申请人: NANJING IASO BIOTECHNOLOGY CO LTD优先权: 2024
CN
WO
2 件公开
GPRC5D and BCMA specific chimeric antigen receptor
CN 122277748 A申请人: JUNO THERAPEUTICS INC优先权: 2022
CN
2 件公开
GPRC5D-targeted single-domain antibody, chimeric antigen receptor and application of GPRC5D-targeted single-domain antibody and chimeric antigen receptor
CN 120005019 A申请人: CHENGDU YOUSAINUO BIOTECHNOLOGY CO LTD优先权: 2023
CN
2 件公开

药物

CAR-GPRC5D

专利

COMBINATION THERAPIES WITH A CELL THERAPY EXPRESSING A GPRC5D-TARGETING CAR AND RELATED METHODS AND USES